(Q38074348)

28 August 2017

1 reference

title

Updates on chemical and biological research on botanical ingredients in dietary supplements (English)

1 reference

28 August 2017

7

Jeanne I Rader

1 reference

28 August 2017

Rahul S Pawar

1

1 reference

28 August 2017

Hemlata Tamta

2

1 reference

28 August 2017

Jun Ma

3

1 reference

28 August 2017

Alexander J Krynitsky

4

1 reference

28 August 2017

Erich Grundel

5

1 reference

28 August 2017

Wayne G Wamer

6

1 reference

28 August 2017

language of work or name

English

0 references

publication date

16 January 2013

1 reference

Analytical and Bioanalytical Chemistry

28 August 2017

published in

1 reference

28 August 2017

volume

405

1 reference

28 August 2017

issue

13

1 reference

28 August 2017

page(s)

4373-4384

1 reference

https://scigraph.springernature.com/pub.10.1007/s00216-012-6691-2

28 August 2017

exact match

0 references

cites work

Dietary supplement use in the United States, 2003-2006

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Use of functional foods among Swedish consumers is related to health-consciousness and perceived effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Pelargonium oil and methyl hexaneamine (MHA): analytical approaches supporting the absence of MHA in authenticated Pelargonium graveolens plant material and oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

DMAA as a dietary supplement ingredient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Use of recreational drug 1,3 Dimethylamylamine (DMAA) [corrected] associated with cerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Studies of methylhexaneamine in supplements and geranium oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Could 1,3 dimethylamylamine (DMAA) in food supplements have a natural origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Bitter gourd (Momordica charantia) is a cornucopia of health: a review of its credited antidiabetic, anti-HIV, and antitumor properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Momordica charantia constituents and antidiabetic screening of the isolated major compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Structures of new triterpenoids and cytotoxicity activities of the isolated major compounds from the fruit of Momordica charantia L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Cucurbitane-type triterpenoids from the stems of momordica charantia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Trinorcucurbitane and cucurbitane triterpenoids from the roots of Momordica charantia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Cucurbitane-type triterpenoids from Momordica charantia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Determination and quantitation of five cucurbitane triterpenoids in Momordica charantia by reversed-phase high-performance liquid chromatography with evaporative light scattering detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Hepatic effects of Cimicifuga racemosa extract in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Oral aloe vera-induced hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Review of liver injury associated with dietary supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Effects of dietary supplements on induction and inhibition of cytochrome P450s protein expression in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Herbal bioactivation, molecular targets and the toxicity relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Usnic acid-induced necrosis of cultured mouse hepatocytes: inhibition of mitochondrial function and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Multiendpoint mechanistic profiling of hepatotoxicants in HepG2/C3A human hepatoma cells and novel statistical approaches for development of a prediction model for acute hepatotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Effects of dietary phenolics and botanical extracts on hepatotoxicity-related endpoints in human and rat hepatoma cells and statistical models for prediction of hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Involvement of Bcl-xL degradation and mitochondrial-mediated apoptotic pathway in pyrrolizidine alkaloids-induced apoptosis in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

In vitro toxicity of kava alkaloid, pipermethystine, in HepG2 cells compared to kavalactones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Toxicity of raw and processed roots of Polygonum multiflorum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Structure elucidation and hepatotoxicity evaluation against HepG2 human cells of neo-clerodane diterpenes from Teucrium polium L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Effects of usnic acid exposure on human hepatoblastoma HepG2 cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Interactive toxicity of usnic acid and lipopolysaccharides in human liver HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Applications of cytotoxicity assays and pre-lethal mechanistic assays for assessment of human hepatotoxicity potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

An in vitro approach to detect metabolite toxicity due to CYP3A4-dependent bioactivation of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Identification of novel pregnane X receptor activators from traditional Chinese medicines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

In vitro screening of 50 highly prescribed drugs for thiol adduct formation--comparison of potential for drug-induced toxicity and extent of adduct formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Screening botanical extracts for quinoid metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Toxicogenomics concepts and applications to study hepatic effects of food additives and chemicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

Proteomics in the search for mechanisms and biomarkers of drug-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

1,3-Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00216-012-6691-2

alpha-Glucosidase inhibition properties of cucurbitane-type triterpene glycosides from the fruits of Momordica charantia

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.58.720

Studies on the constituents of Momordica charantia L. II. Isolation and characterization of minor seed glycosides, momordicosides C,D and E.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.29.1561

Studies on the constituents of Momordica charantia L. I. Isolation and characterization of momordicosides A and B, glycosides of a pentahydroxy-cucurbitane triterpene.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.28.2753

Structures of momordicines I, II and III, the bitter principles in the leaves and vines of Momordica charantia L.

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.32.2044

Identifiers

DOI

10.1007/S00216-012-6691-2

1 reference

28 August 2017

1 reference